Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Lyné van Rensburg, Johann M van Zyl & Johan Smith. (2018) Deposition and transport of linezolid mediated by a synthetic surfactant Synsurf® within a pressurized metered dose inhaler: a Calu-3 model. Drug Design, Development and Therapy 12, pages 1107-1118.
Read now
Read now
Michael DePietro, Ileen Gilbert, Lauren A. Millette & Michael Riebe. (2018) Inhalation device options for the management of chronic obstructive pulmonary disease. Postgraduate Medicine 130:1, pages 83-97.
Read now
Read now
Articles from other publishers (20)
Rejoice Thubelihle Ndebele, Qing Yao, Yan-Nan Shi, Yuan-Yuan Zhai, He-Lin Xu, Cui-Tao Lu & Ying-Zheng Zhao. (2022) Progress in the Application of Nano- and Micro-based Drug Delivery Systems in Pulmonary Drug Delivery. BIO Integration 3:2, pages 71-83.
Crossref
Crossref
Akshay Chandel, Amit K. Goyal, Goutam Ghosh & Goutam Rath. (2019) Recent advances in aerosolised drug delivery. Biomedicine & Pharmacotherapy 112, pages 108601.
Crossref
Crossref
Hiroki Suzuki, Takahiro Mizumoto, Yoshiki Seto, Hideyuki Sato & Satomi Onoue. (2018) Respirable powder formulation of a shortened vasoactive intestinal peptide analog for treatment of airway inflammatory diseases. Journal of Peptide Science 24:3, pages e3069.
Crossref
Crossref
Hideyuki Sato, Hiroki Suzuki, Keisuke Yakushiji, Jennifer Wong, Yoshiki Seto, Robert K. Prud’homme, Hak-Kim Chan & Satomi Onoue. (2016) Biopharmaceutical Evaluation of Novel Cyclosporine A Nano-matrix Particles for Inhalation. Pharmaceutical Research 33:9, pages 2107-2116.
Crossref
Crossref
Yi-Cheng Huang, Rou-Ying Li, Jiun-Yu Chen & Jen-Kun Chen. (2016) Biphasic release of gentamicin from chitosan/fucoidan nanoparticles for pulmonary delivery. Carbohydrate Polymers 138, pages 114-122.
Crossref
Crossref
Abhijeet Pandey & Darshana S. Jain. 2015. Handbook of Polymers for Pharmaceutical Technologies. Handbook of Polymers for Pharmaceutical Technologies
151
172
.
Romain Merlos, Karim Amighi & Nathalie Wauthoz. (2014) Recent Developments in Inhaled Triazoles Against Invasive Pulmonary Aspergillosis. Current Fungal Infection Reports 8:4, pages 331-342.
Crossref
Crossref
Nathalie Wauthoz & Karim Amighi. (2014) Phospholipids in pulmonary drug delivery. European Journal of Lipid Science and Technology 116:9, pages 1114-1128.
Crossref
Crossref
Satomi Onoue, Yoshiki Seto, Masashi Kato, Yosuke Aoki, Yoshiki Kojo & Shizuo Yamada. (2013) Inhalable Powder Formulation of Pirfenidone with Reduced Phototoxic Risk for Treatment of Pulmonary Fibrosis. Pharmaceutical Research 30:6, pages 1586-1596.
Crossref
Crossref
Francesca Ungaro, Ivana d' Angelo, Agnese Miro, Maria I La Rotonda & Fabiana Quaglia. (2012) Engineered PLGA nano- and micro-carriers for pulmonary delivery: challenges and promises. Journal of Pharmacy and Pharmacology 64:9, pages 1217-1235.
Crossref
Crossref
Griffith A. Bell, Elizabeth D. Kantor, Johanna W. Lampe, Danny D. Shen & Emily White. (2012) Use of glucosamine and chondroitin in relation to mortality. European Journal of Epidemiology 27:8, pages 593-603.
Crossref
Crossref
Satomi Onoue, Takuya Matsui, Yosuke Aoki, Hitoshi Ishida, Haruo Nukaya, Keitatsu Kou & Shizuo Yamada. (2012) Self-assembled micellar formulation of chafuroside A with improved anti-inflammatory effects in experimental asthma/COPD-model rats. European Journal of Pharmaceutical Sciences 45:1-2, pages 184-189.
Crossref
Crossref
Satomi Onoue, Yosuke Aoki, Takuya Matsui, Yoshiki Kojo, Shingen Misaka, Takahiro Mizumoto & Shizuo Yamada. (2011) Formulation design and in vivo evaluation of dry powder inhalation system of new vasoactive intestinal peptide derivative ([R15, 20, 21, L17, A24,25, des-N28]-VIP-GRR) in experimental asthma/COPD model rats. International Journal of Pharmaceutics 410:1-2, pages 54-60.
Crossref
Crossref
Nancy Elizabeth Larocca, Dolores Moreno, Jenny Valentina Garmendia & Juan Bautista De Sanctis. (2011) NEW PHARMACOLOGICAL TREATMENTS FOR PATIENTS WITH CHRONIC OBSTRUCTIVE PUMONARY DISEASE (COPD). Biomedical Papers 155:1, pages 43-50.
Crossref
Crossref
Satomi Onoue, Yosuke Aoki, Yohei Kawabata, Takuya Matsui, Kiyoshi Yamamoto, Hideyuki Sato, Yukinori Yamauchi & Shizuo Yamada. (2011) Development of Inhalable Nanocrystalline Solid Dispersion of Tranilast for Airway Inflammatory Diseases. Journal of Pharmaceutical Sciences 100:2, pages 622-633.
Crossref
Crossref
Amit Misra, Anthony J. Hickey, Carlo Rossi, Gerrit Borchard, Hiroshi Terada, Kimiko Makino, P. Bernard Fourie & Paolo Colombo. (2011) Inhaled drug therapy for treatment of tuberculosis. Tuberculosis 91:1, pages 71-81.
Crossref
Crossref
Maria Jose Morilla & Eder Lilia Romero. 2011. Intracellular Delivery. Intracellular Delivery
745
811
.
Satomi Onoue, Shingen Misaka, Yosuke Aoki, Shin-ichiro Karaki, Atsukazu Kuwahara, Asami Ohide, Takahiro Mizumoto & Shizuo Yamada. (2010) Inhalable powder formulation of vasoactive intestinal peptide derivative, [R15,20,21, L17]-VIP-GRR, attenuated neutrophilic airway inflammation in cigarette smoke-exposed rats. European Journal of Pharmaceutical Sciences 41:3-4, pages 508-514.
Crossref
Crossref
Shingen Misaka, Yosuke Aoki, Shin-ichiro Karaki, Atsukazu Kuwahara, Takahiro Mizumoto, Satomi Onoue & Shizuo Yamada. (2010) Inhalable powder formulation of a stabilized vasoactive intestinal peptide (VIP) derivative: Anti-inflammatory effect in experimental asthmatic rats. Peptides 31:1, pages 72-78.
Crossref
Crossref
Ji Youn SohnSo Ri KimSeoung Ju ParkHeung Bum LeeYong Chul LeeYang Keun Rhee. (2009) Comparison for the Effects of Triple Therapy with Salmeterol/Fluticasone Propionate and Tiotropium Bromide versus Individual Components in Patients of Severe COPD Combined with Bronchial Hyperresponsiveness. Tuberculosis and Respiratory Diseases 67:6, pages 536.
Crossref
Crossref